Old Web
English
Sign In
Acemap
>
authorDetail
>
Vivian Prindle
Vivian Prindle
Genomics Institute of the Novartis Research Foundation
Biochemistry
Biology
In vivo
Biosynthesis
Drug
3
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.
2020
Nature Communications
Yue Fu
David Estoppey
Silvio Roggo
Dominik Pistorius
Florian Fuchs
Christian Studer
Ashraf S. Ibrahim
Thomas Aust
Frederic Grandjean
Manuel Mihalic
Klaus Memmert
Vivian Prindle
Etienne Richard
Ralph Riedl
Sven Schuierer
Eric Weber
Jürg Hunziker
Frank Petersen
Jianshi Tao
Dominic Hoepfner
Show All
Source
Cite
Save
Citations (4)
Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.
2020
Nature Communications
Yue Fu
David Estoppey
Silvio Roggo
Dominik Pistorius
Florian Fuchs
Christian Studer
Ashraf S. Ibrahim
Thomas Aust
Frederic Grandjean
Manuel Mihalic
Klaus Memmert
Vivian Prindle
Etienne Richard
Ralph Riedl
Sven Schuierer
Eric Weber
Jürg Hunziker
Frank Petersen
Jianshi Tao
Dominic Hoepfner
Show All
Source
Cite
Save
Citations (0)
Dark chemical matter as a promising starting point for drug lead discovery
2015
Nature Chemical Biology
Anne Mai Wassermann
Eugen Lounkine
Dominic Hoepfner
Gaelle Le Goff
Frederick J. King
Christian Studer
John M Peltier
Melissa L Grippo
Vivian Prindle
Jianshi Tao
Ansgar Schuffenhauer
Iain M. Wallace
Shanni Chen
Philipp Krastel
Amanda Cobos-Correa
Christian N. Parker
John W. Davies
Meir Glick
Show All
Source
Cite
Save
Citations (85)
1